Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Empowering Excellence: How Our Dedicated Team Elevates Care for Injured Employees
Our employees’ unwavering dedication to continuous improvement and quality assurance lies at the heart of our customer-centric approach, utilizing data to enhance outcomes for injured employees. They leverage every tool and resource to ensure each client receives the highest standard of care.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.
The Regulatory Rollercoaster: A High-Stakes Game of Collaboration and Adaptability
As the workers' compensation and auto industry braces itself for the regulatory changes sweeping across Michigan, Florida and California, one thing is clear—collaboration, adaptability and a keen eye for detail will be the keys to succeeding at this high-stakes game.
6 Considerations for Medical Transportation Arrangements for Injured Employees
Beyond convenience, reliable transportation prevents missed appointments that can delay recovery and worsen health outcomes. Here are some valuable tips for arranging medical transportation effectively.
Current Used Vehicle Market Conditions: Q2 2024
Wholesale prices fell for the second consecutive month in May and continued to fall into mid-June, as the less-than-impressive 2024 Spring/tax season market came to an early close. Nevertheless, wholesale and retail used vehicle market conditions are amenable to a less dramatic ongoing decline in prices than seen last year, as much of the correction to historical patterns of depreciation, seasonality and price-spread versus new vehicles has already taken place.
Out-of-Network Dispensing Channels and Their Unique Challenges
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part two of our annual drug trends series. In this short video they will discuss aggregate trends and challenges within our combined in- and out-of-network channels to address the total view of prescription activity.